Insecticides India Ltd

Q1 FY27Fertilizers & Agrochemicals

Insecticides India Ltd Q1 FY27 Results & Concall Highlights: Revenue, Margins & Order Book

Q1 FY27 earnings call: what management guided on revenue, margins and order book.

Price₹578

Market cap₹1.8K Cr

P/E14.7

Updated25 Aug 2026

Read4 min read

What the Q1 FY27 call signalled

1 of 3 strong

RevenueRank 4

MarginRank 3

CapexYes

Not discussed on this call: fundraise, order book.

The short version

Future growth expectations for Insecticides (India) Limited based on the transcript: - Expect stronger execution and growth from Q2 onwards as delayed monsoons normalize. Management aims to improve revenue growth, gross margins, profitability, and cash generation with sharper execution in coming quarters.

From Insecticides India Ltd's Q1 FY27 earnings-call transcript · updated 25 Aug 2026.

Revenue & Sales Performance

Rank 4

Future growth expectations for Insecticides (India) Limited based on the transcript: - Expect stronger execution and growth from Q2 onwards as delayed monsoons normalize. - Target to double sales in 4 to 5 years compared to doubling in 3-4 years previously. - Dahej and Sotanala expansions underway to support increased capacity and enable growth. - New product launches (e.g., Granuvia, Spinoace) expected to contribute INR 30-35 crores in FY27. - Focus on increasing premium product contribution from 64% to 70% in next 3-4 years. - Kaeros Research growing rapidly with a targeted CAGR of 100% initially, then 50-60%. - Working capital improvements and asset utilization optimization to boost returns. - At least INR 200 crores revenue addition expected from Dahej plant after stabilization. - Positive outlook despite Q1 setbacks; revised targets expected post Q2 review.

Profitability & Margins

Management aims to improve revenue growth, gross margins, profitability, and cash generation with sharper execution in coming quarters.
Q1 saw a setback with 13% volume decline and 2% price rise; better performance is expected in Q2 with improved sales.
Premium product contribution increased to 64% of B2C sales, targeting 70% in 3-4 years, supporting margin expansion.
New product launches like Granuvia and Spinoace expected to generate INR 30-35 crores gross revenue in FY'27.
Capacity expansions at Dahej and Sotanala facilities (technical and formulation plants) to support sales growth and operational efficiency.
Cost control measures (solar, wind energy usage, steam boilers) underway to maintain expenses.
ROCE improvement is a key focus, with ongoing initiatives to improve working capital, inventory turns, and reduce credit days.
Kaeros business targeting high growth CAGR initially at 100%, margin expected to remain single-digit initially.
Overall strategy targeting doubling sales in 4-5 years, with focus on leveraging investments and enhancing operating leverage.

See what Insecticides India Ltd said on profitability & margins — free account, 30 seconds.

Capital Expenditure Plans

Yes

Total investment for Sotanala formulation and technical plant: approx. INR 200 crores (INR 50 crores for formulation, INR 150 crores for technical). About INR 70 crores invested so far.
Dahej facility fully commercialized (~70%), remaining parts soon. Sotanala plant Phase 1 expected completion by Diwali; Phase 2 under building erection stage.
Sotanala technical plant to manufacture 5-6 identified insecticides and fungicides in Phase 1, with new AI technicals in Phase 2.
Expansion is continuous with additional investment at Udhampur for dedicated herbicide and insecticide plants within this year.
Post current projects, annual capex expected to normalize to INR 30-40 crores (maintenance capex).
Focus to shift towards utilization, cash generation, returns, and improving capital efficiency.
Strategic initiatives include investments in premiumization, R&D, technology partnerships, and Kaeros Research to build diversified growth platforms.

Top-ranked in Fertilizers & Agrochemicals

Ranked on what management guided this quarter

5x potential

1Anya Polytech &₹180 Cr

Rev 2Mar 1

2Dharmaj Crop Guard Ltd₹911 Cr

Rev 2Mar 2

3₹5.6K Cr

Rev 2Mar 3

4₹1.3K Cr

Rev 3Mar 1

5₹56.9K Cr

Rev 3Mar 3

Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.

Fundraising & Capital Structure

The document does not explicitly mention any current or future fundraising plans through debt or equity. However, from the discussion, some relevant points are: - Expansion and capacity-building initiatives are ongoing, with investments like the INR 200 crores for the Sotanala plant (INR 150 crores for technicals, INR 50 crores for formulation). - No direct mention of raising new capital via debt or equity to fund these expansions. - Buyback of shares is discussed as a usual process every 2-3 years, dependent on company performance, but no immediate buyback planned. - The company expects capex to normalize to INR 30-40 crores annually for maintenance after current projects, focusing more on utilization and cash generation. - Management emphasizes working on improved cash generation and capital efficiency, with no indication of external fundraising needs at present. Therefore, no explicit plans for new fundraising through debt or equity are communicated.

See what Insecticides India Ltd said on fundraising & capital structure — free account, 30 seconds.

Order Book & Pipeline

The transcript from the Insecticides (India) Limited Q1 FY 2027 earnings call does not explicitly mention details about the current or expected order book or pending orders. However, some relevant points related to demand and business outlook include: - Demand environment impacted by delayed monsoons but improving with better rainfall and crop health. - Strategic caution in product placements to reduce sales returns seen last year. - Growth opportunities from product launches, farmer engagement, international business, and capacity investments. - International business gaining momentum with registrations and partnerships progressing. - Focus on converting investments in manufacturing and R&D into stronger sales and cash generation. - Normalization expected over remaining quarters with improving execution. No specific quantified details or figures on order books or pending orders are provided in the transcript.

Insecticides India Ltd — Quarterly revenue & net profit

Revenue Net profit

Sep 2024

Dec 2024

Mar 2025

Jun 2025

Sep 2025

Dec 2025

Reported quarterly figures (₹ Cr). Latest: revenue ₹385 Cr, net profit ₹10 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.

Full financials →

What Insecticides India Ltd's management said in earlier quarters

Others in Fertilizers & Agrochemicals this season

Indogulf Cropsciences Ltd (Q1 FY27)
1800+ crores within 2-3 years. Key concall takeaways from Indogulf Cropsciences Ltd's Q1 FY27 earnings call — and how it ranks against sector peers.
Gujarat State Fertilizers & Chemicals Ltd (Q1 FY27)
Profit after tax increased by 15% YoY in Q1 FY27, signaling positive growth trajectory. Key concall takeaways from Gujarat State Fertilizers & Chemicals Ltd's…
GSP Crop Science Ltd (Q1 FY27)
Capacity utilization indicates room for growth: 70-75% for technical and 25-30% for formulations. Key concall takeaways from GSP Crop Science Ltd's Q1 FY27…
Rallis India Ltd (Q1 FY27)
. Key concall takeaways from Rallis India's Q1 FY27 earnings call — and how it ranks against sector peers.

Compare:vs Coromandel International Ltd vs Fertilizers & Chemicals Travancore Ltd vs UPL Ltd

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Frequently Asked Questions

What were Insecticides India Ltd Q1 FY27 results?

What is Insecticides India Ltd share price analysis?

Insecticides India Ltd currently shows a neutral. The stock trades at a P/E of 14.7 with a market cap of ₹1,837 Cr. Investors should review the full earnings analysis for detailed insights.

Is Insecticides India Ltd planning capital expenditure?

Total investment for Sotanala formulation and technical plant: approx.

Keep Insecticides India Ltd on your radar — track it to get its next earnings analysis in your feed.

This analysis is AI-generated based on publicly available earnings data and concall transcripts. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.